Zura Bio
ZURA
74 hedge funds and large institutions have $59M invested in Zura Bio in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 19 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 20
1.16% more ownership
Funds ownership: 65.69% → 66.85% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less funds holding
Funds holding: 87 → 74 (-13)
45% less capital invested
Capital invested by funds: $107M → $59M (-$48.3M)
68% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 19
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $15K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
+$4.73M |
| 2 |
AI
Allostery Investments
Stamford,
Connecticut
|
+$1.28M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$1.14M |
| 4 |
Renaissance Technologies
New York
|
+$462K |
| 5 |
Two Sigma Advisers
New York
|
+$117K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$750K |
| 2 |
BCM
Boxer Capital Management
San Diego,
California
|
-$750K |
| 3 |
Millennium Management
New York
|
-$627K |
| 4 |
SCM
Superstring Capital Management
New York
|
-$467K |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$440K |
ZURA Hedge Fund Activity: Q1 2025 in Review
74 of the 7,466 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q1 2025, worth a combined $59M — down 45% from $107M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of ZURA and 6 opened new positions — a net loss of 13 holders — while 20 trimmed existing stakes and 24 added.
The largest buyer was VR Adviser, adding an estimated $4.73M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $750K sold.
- 74 institutional investors held Zura Bio (ZURA) as of Q1 2025, down from 87 in Q4 2024.
- Funds reported $59M of Zura Bio stock for Q1 2025, down 45% quarter-over-quarter.
- 6 funds opened new Zura Bio positions in Q1 2025 and 19 closed out, a net change of -13 holders.
- The largest Zura Bio buyer in Q1 2025 was VR Adviser, an estimated $4.73M added.
- The largest Zura Bio seller in Q1 2025 was Adage Capital Partners, an estimated $750K sold.
Based on aggregated 13F filings for Q1 2025.